Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3 (Q57279421)

6

0 references

Jaume Ordi

object named as

Jaume Ordi

8

0 references

author name string

Immaculada Alonso

1

0 references

Aureli Torné

2

0 references

Luis M. Puig-Tintoré

3

0 references

Roser Esteve

4

0 references

Llorenç Quinto

Natural history of cervical neoplasia: defining progression and its consequence

5

0 references

language of work or name

English

0 references

publication date

November 2006

0 references

published in

Gynecologic Oncology

0 references

volume

103

0 references

issue

2

0 references

page(s)

631-636

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Natural history of dysplasia of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Treatment outcomes for squamous intraepithelial lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Negative predictive value of human papillomavirus test following conization of the cervix uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Cervical intraepithelial neoplasia III: long-term outcome after cold-knife conization with clear margins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Residual and recurrent disease after laser conization for cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Efficacy and safety of large-loop excision of the transformation zone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Persistence of Human Papillomavirus Infection after Therapeutic Conization for CIN 3: Is It an Alarm for Disease Recurrence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Contribución de la detección del virus del papiloma humano de alto riesgo al estudio de las lesiones premalignas y malignas del cérvix uterino

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Human papillomavirus load in Hybrid Capture II assay: Does increasing the cutoff improve the test?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Determination of Human Papillomavirus (HPV) Load and Type in High-Grade Cervical Lesions Surgically Resected from HIV-Infected Women during Follow-up of HPV Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016

Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.016